Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabonomics/Lipidomics”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableLooking for participantsNCT05727020
What this trial is testing

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma

Who this might be right for
PDAC - Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Imperial College London 1,005
Not applicableLooking for participantsNCT06915389
What this trial is testing

Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients

Who this might be right for
Gastric CancerImmunotherapyAdverse Event+2 more
Qinghai Red Cross Hospital 100
Not applicableLooking for participantsNCT04931537
What this trial is testing

Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.

Who this might be right for
Diabetic Nephropathy Type 2Biomarker
Second Affiliated Hospital, School of Medicine, Zhejiang University 1,000
Not applicableLooking for participantsNCT05412758
What this trial is testing

Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)

Who this might be right for
Volatile Organic CompoundsMicrobiomeMicrobioata+7 more
Imperial College London 648
Post-approval studies (Phase 4)Ended earlyNCT02570789
What this trial is testing

Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 90